S100A9 and early-onset autosomal dominant Alzheimer disease: Moreover, S100A9 co-aggregates and forms joint complexes with major amyloid polypeptides, such as amyloid β (Aβ) peptide in Alzheimer’s disease [11,18] and with α-synuclein in Parkinson’s [12].